Multiple Migosis Advantages And Disadvantages

Multiple sclerosis, also known as MS, is one of humankind’s most mysterious diseases. No one knows the exact cause and there is no exact treatment. Still multiple sclerosis has the ability to affect nearly 3 million people worldwide and at least 500,000 people in the United States (Boroch). This disease tends to be more common in individuals of northern European descent and women are more than twice as likely to develop multiple sclerosis as men. Of those 3 million people, most of them are between the ages of 20 and 50 years old (Dangond). Even though multiple sclerosis is a mystery disease, scientists are working to determine the exact cause and treatment.

Thesis: Multiple sclerosis brings daily challenges to whomever struggles with it, but with the right team of doctors and medication, it can be maintained.

There are many debilitating side effects and symptoms that accompany Multiple Sclerosis (MS). In MS, the immune system essentially fights itself and attacks its own body’s cells, causing progressive damage in the brain and spinal chord. Some key symptoms and side effects of the disease are vision problems, muscle weakness, and trouble walking or speaking. However, this is not it, There are many more side effects and symptoms that very between individuals. Some of the symptoms that haven't thoroughly been researched are the changes that occur in the brain of an MS patient, especially a pediatric MS patient. There are several existing hypothesis about Multiple Sclerosis’ debilitating effects in the brain, but no concrete research done on the

Multiple Sclerosis, commonly known as MS is an autoimmune disease of the central nervous system. Scientists have been studying MS since the 19th century. In MS, the body’s immune system produces cells and antibodies that attack myelin in your brain which is essential for the nerves in your brain and spinal cord to conduct electricity to perform its function. The attack on myelin results in vison loss, paralysis, numbness, muscle weakness, difficulty walking, stiffness, spasms, and bladder and bowel problems. MS has varying degrees of severity and affects people between the ages of 20-50, mostly women. Although there are treatments, there is no cause and cure yet.

Even though MS effects every individual differently and can run its course in a strikingly different manner than that of another, four basic disease courses have been

One day seven years ago, Kimberly Macalaster-Klapprodt, woke up to find that the upper left part of her face was numb. “I thought, ‘This is weird’ and went on with my day. But when she developed dizziness and a crippling headache the next day, she stopped joking and went to an urgent care facility. That’s when the saga of Macalaster-Klapprodt’s multiple sclerosis (MS) diagnosis began. It was exhausting experience that many patients who are eventually diagnosed with MS can relate to. Although there's no cure for Multiple Sclerosis, the sooner a patient receives an MS diagnosis, the sooner he or she can be treated with medications that help manage the disease, especially in the initial stages of Multiple Sclerosis

Individuals suffering from MS face continually worsening symptoms leading to progressing disability and early mortality. There is currently no cure and current treatments have negative impacts on the life of the individual receiving the treatment. The story of the discovery and understanding of the disease spans to almost two centuries of medical research and still there is much to understand. Autoimmune disorders are becoming more common in our society and it is crucial to understand the cause of these diseases and to develop better treatments. In the two centuries of research, the life expectancy of an individual with MS has increased dramatically. Upon diagnosis in the late 1800's and early 1900's individuals had an average life span of 10 years but today, due to advances in medical technologies, individuals with MS may live 30 years or more. More research is required to understand how to better treat this disease or prevent the initial autoimmune response from

Multiple Sclerosis is hard to diagnose; early signs of MS are non-specific and the individual may appear to have another disease (“NMSS,” 2012). It is still unclear how multiple sclerosis is inherited, although the disease does appear to be passed down over family generations. Most people exhibit symptoms for the disease between the ages of 20-40 years old; symptoms can vary depending on the individual and can range anywhere from mild to extremely painful (“NINDS,” 2015). People manage their symptoms in different ways including prescription

Multiple sclerosis (also known as MS) is an autoimmune disease which affects the spinal cord and brain (central nervous system). It is considered to be one of the most mysterious diseases because there are no exact recognition on its causes; there is no cure as well. Rather, treatment is used to prevent its attacks. The common mechanism of multiple sclerosis is the failure of myelin to produce cells because of the destruction of the immune system. Myelin is part of a neuron which helps propagation of impulses (electrical messages) of the central nervous system. It is also an essential part of the central nervous system. The United States,

Multiple sclerosis is a prolonged, progressive, wasting disorder of the Central Nervous System categorized by distributed demyelination of nerve fibers of the brain and spinal cord. The onset of MS is usually between 20 and 50 years of age, although it can occur in young teens and much older adults. Women are affected two of three times more often than men. (Lewis, Dirksen, Heitkemper, Bucher, & Camera, 2014, p. 1428)

Normally, when a person is diagnosed with multiple sclerosis there is an immediate impact on all people who love them most. People with multiple sclerosis are constantly in need of assistance to do their daily tasks since their cognitive and functional impairments. This care is provided by informal caregivers who take care of the patient without being paid for their services. Eventually, the patient and carers are placed under immense strain and burden of the disease.

It affects everyone differently, because the severity and types of MS differ from person to person. The exact cause of MS is still unknown. The signs and symptoms of MS are blurred or double vision, thinking problems, clumsiness or lack of coordination, loss of balance, numbness, tingling, and weakness in an arm or leg. In order to determine if it is really MS, a medical doctor most likely a neurologist will perform several tests to diagnose it. A neurological exam will check for reduced nerve function, an eye exam will check for distortions in the inner eye and response times, a spinal tap will involve taking a sample of spinal fluid which will be removed with a long needle and go to be tested. There is no treatment for MS. Treatment typically focuses on speedy recovery from attacks, slowing the progression of the disease and managing MS symptoms. Some people have such mild symptoms that treatment is not required. Treatments for MS attacks are corticosteroids, such as oral prednisone and intravenous methylprednisolone, are prescribed to reduce nerve

Environment, lifestyles, vitamins and even genetics don’t play a role in this disease. MS is classified into four types: relapsing-remitting disease (RRMS), primary progressive (PPMS), secondary progressive (SPMS) and lastly progressive relapsing (PRMS). In the RRMS stage, patients symptoms respond to treatment then resolve. In PPMS stage, the symptoms progress over time without remission or improvement. The SPMS stage is when exacerbation doesn’t fully resolve during the remission. In time, the patient continues with progressive debility. During the PRMS phase, the patient experiences escalating symptoms as well as intermittent episodes of remissions. There is medicine that can help slow down the progression of MS and help control the symptoms but not cure multiple

This study investigated the benefits of an exercise program for MS patients. Data for heart rate, fatigue, and quality of life were collected at the start, and after 3-months and 6-months. The changes were compared using the

The sample sizes would be large, in order to represent the large population of individuals in the United States that are affected by MS. The controls would be used as a comparison as well as to ensure no bias in data collection. The criteria for choosing MS patients would be individuals ranging from 20 to 60 years of age, having sufficient documentation of being diagnosed with MS, and having no documentation or suspicion of having any other inflammatory disease of the CNS. The criteria for choosing the control samples would be individuals ranging from 20 to 60 years of age, having no documentation of or suspicion of having any inflammatory diseases of the CNS, and having no documentation of or suspicion of having infections of the GI tract within the last 10 years. The age restraint was chosen based on the fact that development of MS begins between 20 to 40 years of age.